Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Remote glucose check

This article was originally published in The Gray Sheet

Executive Summary

Scottsdale, Ariz., health technology firm MedApps gains 510(k) clearance for its d-PAL remote monitoring system for diabetics July 3. The system connects to Johnson & Johnson/LifeScan's One Touch Ultra glucose monitor to allow wireless transfer of daily glucose readings to a central server. Patients can interact with the system via cell phone and remotely answer additional questions to give their doctors other pertinent information. MedApps, founded in July 2006, is developing similar products to monitor blood pressure in congestive heart failure patients, breathing efficiency for respiratory diseases, tremors in Parkinson's disease, and for use with implantable defibrillators and pacemakers...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT025005

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel